吉大一院

服热:0431-88782291

务线:0431-88783456

Email举报:jdyyjjjcb@126.com

电话举报:0431-88782312

近三年发表的主要SCI文章

作者:吉大一院 时间:2012-02-13 13:55:30 编辑:

  

     

    近三年发表的SCI文章

1.  Kong F, Pan Y, Chi X, Wang X, Chen L, Lv J, Sun H, Wu R, Jin J, Yu G, Ma Z, Wang Y, Huang X, Li H, Bai Y, Jia J, Minuk GY, Zhong J, Sun B, Jiang J, Niu J*.Factors associated with spontaneous clearance of hepatitis C virus in Chinese population. Biomed Res Int. 2014 (IF=2.706)

2.  Zou X, Chi X, Pan Y, Du D, Sun H, Matsuda A, Li W, Kuno A, Zhang X, Narimatsu H, Niu J*, Zhang Y. LecT-Hepa facilitates estimating treatment outcome during interferon therapy in chronic hepatitis C patients. Clin Proteomics. 2014 Dec 11;11(1):44. (IF=2.68)

3.  Zhai N, Chi X, Li T, Song H, Li H, Jin X, Crispe IN, Su L, Niu J, Tu Z. Hepatitis C virus core protein triggers expansion and activation of CD4+CD25+ regulatory T cells in chronic hepatitis C patients Cell Mol Immunol. 2014 Dec 22. doi: 10.1038/cmi.2014.119. ( IF= 4.185)

4.  Tian S, Chang HH, Wang C, Jiang J, Wang X, Niu J*. Multi-TGDR, a multi-class regularization method, identifies the metabolic profiles of hepatocellular carcinoma and cirrhosis infected with hepatitis B or hepatitis C virus. BMC Bioinformatics. 2014 Apr 4;15:97.( IF= 2.672)

5.  infection.Hu X, Jiang Y, Li X, Gao Y, Guo X, Chi X, Yan H, Feng J, Zhong J, Sun B, Shao X, Xiao W, Pan Y, Niu J*Long-term effect on natural killer cells by interferon-α therapy on the outcomes of HCV. J Interferon Cytokine Res. 2014 May;34(5):366-75. ( IF= 3.899)

6.  Haibo Sun#, Yu Pan#, Ruihong Wu, Juan Lv, Xiumei Chi, Xiaomei Wang, ZhengKun Tu, Jin Zhong, Bin Sun, Yang Liu, Jing Jiang*, Junqi Niu*CD24 Ala57Val Polymorphism is Associated with Spontaneous Viral Clearance in the HCV-Infected Chinese Population. Liver International (accepted, IF= 4.412).

7.  Minwei Sui. Ruihong Wu. Xiaoli Hu. H. Zhang. J. Jiang . Y. Yang and J. Niu*,Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population. Journal of Viral Hepatitis, 2014. (accepted, IF= 3.307).

8.  Lin-Jiao Chen, Xiao-Yu Wen, Jun-Qi Niu*, Role of PNPLA3 polymorphism in pathogenesis of liver diseases, World Chinese Journal of Digestology,2013-03-18,Volume 21,Issue 8 (SCI, IF=0.775)

9.  Liu Y, Gao P*. Modulation of hepatitis B surface antigen secretion by annexin II expressed in hepatitis B virus‑producing hepatoma cells, Mol Med Rep. 2014 Dec;10(6):3113-7 ( IF= 1.484)

10. Sun H, Lv J, Tu Z, Hu X, Yan H, Pan Y, Xu D, Lian Z, Chi X, Niu J*, Antiviral treatment improves disrupted peripheral B lymphocyte homeostasis in chronic hepatitis B virus-infected patients, Exp Biol Med (Maywood). 2013 Nov 1;238(11):1275-83 (SCI, IF= 2.803)

11. Zhang M, Wu R, Jiang J, Minuk GY, Niu J*, The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis, Alcohol. 2013 Nov;47(7):553-8(SCI, IF= 2.255)

12. Qi Y, Xiang Y, Wang J, Qi Y, Li J, Niu J*, Zhong J, Inhibition of hepatitis C virus infection by polyoxometalates, Antiviral Res. 2013 Nov;100(2):392-8(SCI, IF= 3.925)

13. Ding Y, Zhang H, Li Y, Wu D, He S, Wang Y, Li Y, Wang F, Niu J*, Inhibition of HCV 5'-NTR and core expression by a small hairpin RNA delivered by a histone gene carrier, HPhA, Int J Med Sci. 2013 Jun 9;10(8):957-64(SCI, IF= 2.065)

14. Jin Q, Moritoki Y, Lleo A, Tsuneyama K, Invernizzi P, Moritoki H, Kikuchi K, Lian ZX, Hirschfield GM, Ansari AA, Coppel RL, Gershwin ME, Niu J*. Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis. Hepatology. 2012 May;55(5):1495-506. doi: 10.1002/hep.25511. Epub 2012 Apr 4.  (SCI, IF=11.665)

15. Hong Z, Yanfang J, Shumei H, Jie S, Qing G, Xiangwei F, Bing D, Wei W, Xiaodong S, Chunyan W, Siqi Z, Wanyu L, Junyan F, Junqi N*, Relationship between serum aminotransferase levels and metabolic disorders in northern China, Turk J Gastroenterol. 2012;23(6):699-707 (SCI, IF= 0.484)

16. Zhang H, Qi Y, Ding Y, Wang J, Li Q, Zhang J, Jiang Y, Chi X, Li J, Niu J*. Synthesis, characterization and biological activity of a niobium-substituted-heteropolytungstate on hepatitis B virus. Bioorg Med Chem Lett. 2012 Feb 15;22(4):1664-9. Epub 2012 Jan 2. (SCI, IF=2.554)

17. Ma L, Cai YJ, Yu L, Feng JY, Wang J, Li C, Niu JQ*, Jiang YF.  Treatment with Telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B. Antimicrob Agents Chemother. 2012 Dec 28. [Epub ahead of print] (SCI, IF=4.841)

18. Juan Lv, Qinglong Jin, Haibo Sun, Xiumei Chi, Xiaoli Hu, Hongqing Yan, Yu Pan,Weihua Xiao, Zhigang Tian, Jinlin Hou, Damo Xu, Zhengkun Tu, and Junqi Niu*. Antiviral Treatment Alters the Frequency of Activating and Inhibitory Receptor-Expressing Natural Killer Cells in Chronic Hepatitis B Virus Infected Patients, Mediators of Inammation, 2012, doi:10.1155/2012/804043 (SCI, IF=3.2)

19. Di Wu, Jun-Qi Niu*, Yan-Hua Ding, Xin-Yu Wu, Bo-Hua Zhong, Xiang-Wei Feng Antiviral effects of three novel derivatives of adefovir on the replication of hepatitis B virus. Medicinal Chemistry Research July 2012, Volume 21, Issue 7, pp 1179-1187   (SCI, IF=1.271)

20. Zhou L, Ding L, Yin P, Lu X, Wang X, Niu J, Gao P*, Xu G. Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry.J Proteome Res. 2012 Nov 2;11(11):5433-42. doi: 10.1021/pr300683a. Epub 2012 Sep 28.(SCI, IF=5.113)

21. Hu X, Chen H, Jin M, Wang X, Lee J, Xu W, Zhang R, Li S, Niu J*. Molecular cytogenetic characterization of undifferentiated embryonal sarcoma ofthe liver: a case report and literature review. Molecular Cytogenetics 2012, 5:26 doi:10.1186/1755-8166-5-26 (unofficial Impact Factor of 1.82)

22. Lei Yu, Yan-Fang Jiang, Lei Sun, Bo-Hua Zhong and Jun-Qi Niu*. EBHU18, a novel derivative of fatty acid bile acid conjugates, prevents cholesterol gallstone formation in experimental mice. Medicinal Chemistry Research. 2012; 21(11) 3382-3389, DOI: 10.1007/s00044-011-9828-5 (SCI, IF=1.271)

23. Shi X, Pan Y, Wang M, Wang D, Li W, Jiang T, Zhang P, Chi X, Jiang Y, Gao Y, Zhong J, Sun B, Xu D, Jiang J, Niu J*. IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS One. 2012;7(5):e37054. Epub 2012 May 23.    (SCI, IF=4.092)

24. Wang X, Zhu C, Bao W, Zhao K, Niu J*, Yu XF, Zhang W. Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS One. 2012;7(3):e32405. Epub 2012 Mar 29.     (SCI ,IF=4.092)

25. Feng J, Hu X, Guo H, Sun X, Wang J, Xu L, Jiang Z, Xu B, Niu J*, Jiang Y. Patients with chronic hepatitis C express a high percentage of CD4(+)CXCR5 (+) T follicular helper cells. J Gastroenterol. 2012 Sep;47(9):1048-56. Epub 2012 Mar 17.  (SCI, IF=4.16)

26. Wang J, Zhao P, Guo H, Sun X, Jiang Z, Xu L, Feng J, Niu J*, Jiang Y. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C. Mediators Inflamm. 2012;2012:819636. Epub 2012 Jan 24.   (SCI, IF=3.263)

27. Wang J, Cai Y, Ji H, Feng J, Ayana DA, Niu J, Jiang Y. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B. J Interferon Cytokine Res. 2012 Jun;32(6):248-53. Epub 2012 Feb 3.     (SCI, IF=3.063)

28. He D, Sun L, Li C, Hu N, Sheng Y, Chen Z, Li X, Chi B*, Jin N.Anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of Newcastle disease virus in vitro and in vivo, Viruses. 2014 Feb ( IF= 3.279)

29. Huang WL, Li YG, Lv YC, Guan XH, Ji HF, Chi BR*, Use of lectin microarray to differentiate gastric cancer from gastric ulcer, World J Gastroenterol. 2014 May 14;20(18):5474-82SCI,(SCI  IF=2.547)

30. Li B, Wang L, Chi B*,Upregulation of periostin prevents P53-mediated apoptosis in SGC-7901 gastric cancer cells, Mol Biol Rep. 2013 Feb;40(2):1677-83(SCI  IF=2.02)

31. Jin F, Ji H, Jia C, Brockmeier U, Hermann DM, Metzen E, Zhu Y, Chi B*,Synergistic antitumor effects of endostar in combination with oxaliplatin via inhibition of HIF and CXCR4 in the colorectal cell line SW1116,PLoS One. 2012;7(10):e47161(SCI  IF=4.41)

32. Liu L, Wu W, Zhu G, Liu L, Guan G, Li X, Jin N, Chi B*. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma. Int J Mol Med. 2012 Oct;30(4):747-54(SCI  IF=2.08)

33. Huifan Ji, Antitumor Effects of Newcastle Disease Virus Hemagglutinin-neuraminidase Used as a Molecular Adjuvant, 高等学校化学研究, 201304:29(2):270-274  (SCI, IF=0.735)

34. Huifan Ji, High frequencies of CD158b+ NK cells are associated with persistent hepatitis C virus infections, Annals of hepatology, 201307, 12(4):539-47 (SCI, IF=1.607)

35. Huifan Ji, Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment. J Interferon Cytokine Res, 201310, 33(10):612-8. (SCI, IF=3.297)

36. Huifan Ji, Liver injury and serum interleukin-37 in chronic hepatic B and C patients, Hepatology International  201306 ,7(suppl1):s326

37.  Huifan Ji, Tfh and plasma cells are correlated with hypergammaglobulinaemia in patients with autoimmune hepatitis,liver international,2013

38. Yanjun Cai, Treatment with telbivudine positively regulates antiviral immune profiles in chinese patients with chronic hepatitis B. Antimicrob Agents Chemother, 57(3):1304-11. (SCI, IF=4.56)

39. Li Sun, Shuhua Wang, Yajun Li, Yongfang Liu, Zhenzhen Tian, Runping Gao*.  IgG4-related autoimmune pancreatitis overlapping With Mikuliczs disease and lymphadenitis: A case report.The American Journal of Gastroenterology. 2013; 108(Suppl):S66:211(SCI, IF=7.553)

40. Shuahua Wang, Ming Xiu, Rongli Piao, Runping Gao*. A Case Report of Gastric Cancer Complicated with IgG4-Related Disease. The American Journal of Gastroenterology. 2013;108(Suppl):S46:146 (SCI, IF=7.553)

41. Lu Zhang, Shuhua Wang, Qiang Zhou, Runping Gao*. Autoimmune Hepatitis Associated with Sjogrens Syndrome: A Case Report. The American Journal of Gastroenterology. 2013;108(Suppl):S134:450 (SCI, IF=7.553)

42. Li-Mei Qu, Ya-Hui Liu, David R Brigstock, Yong-Fang Liu, Ya-Jun Li, Runping Gao*. IgG4-related autoimmune pancreatitis overlapping With Mikuliczs disease and lymphadenitis: A case report. World J Gastroenterol 2013; 19(48): 9490-9494  (SCI, IF=2.547)

43. Sun L, Zhou Q, Brigstock DR, Yan S, Xiu M, Piao RL, Gao YH, Gao RP*. Focal autoimmune pancreatitis and chronic sclerosing sialadenitis mimicking pancreatic cancer and neck metastasis. World J Gastroenterol. 2014 Dec 14 (IF= 2.43).

44. Xiu M, Liu YH, Brigstock DR, He FH, Zhang RJ, Gao RP*, Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth, World J Gastroenterol. 2012 Dec 21;18(47):7070-8. (SCI, IF=2.547)

45. Piao RL, Brigstock DR, Zhu J, Zhang ML, Gao RP*, Clinical significance of connective tissue growth factor in hepatitis B virus-induced hepatic fibrosis World J Gastroenterol. 2012 May 14;18(18):2280-6(SCI, IF=2.547)